Global 3D Cell culture Market
- MAR2978574
- 176 Pages
- August 2018
- Pharmaceuticals
Market Dynamics
Due to increasing prevalence of various types of cancer, the focus on finding an effective and affordable cure for cancer has expanded. Thus one of the primary drivers in the 3D cell culture market is increased investment in healthcare, R&D, and other research-related activities. Large-sized companies have focused on product launch to cater to the specific requirements of the researchers, whereas the novelty of customized 3D cell culture products has encouraged small companies to enter the market. Further, the demand for 3D cell culture products has been fuelled by the potential of this technology to replace and reduce the usage of animal models for histological analysis and biochemical assays thus driving growth in the coming years. Also, the emergence of technology with respect to spheroid formation and matured assay methods is expected to foster the emergence of 3D optimized assays, kits, and protocols, in turn, expediting the entire research process.
Market Segmentation
The market is segmented in terms of technology, end users, applications, and geography. In terms of technology, the market is segmented majorly into scaffold-based platforms and scaffold-free platforms. Scaffold-free is further subdivided into microfluidic, magnetic levitation, 3D petrisidhes, ultra-low attachment plates, 3D bioreactors & 3D bioprinting. Scaffold-based is also further sub-segmented into hydrogels/ecmanalogs, solid scaffolds, and micropatterned surfaces. Applications covered in the study include cancer, stem cell research, drug discovery, regenerative medicine, 3D printing microfluidics and others. On the basis of end user, the market is categorized into biotechnology & pharmaceutical companies, academic institutes and contract research laboratories.
Regional/Geographic Analysis
The market can be segmented on the basis of geography into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K., France, Germany, China, Japan, Brazil, and GCC countries.
Key Players
Some of the major players in the market Lonza, Merck, Nano3D Biosciences, 3D Biotek, Global Cell Solutions, Corning, Emulate, and Thermo Fisher Scientific.
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
1.1. Market Definition
1.2. Market Taxonomy
2. Research Methodology
3. Assumptions and Acronyms
4. Executive Summary
5. Consumer Analysis
5.1. Consumer Profile (Demographic, Geographic, etc.)
5.2. Consumer Motivation
5.3. Procurement Process
5.4. Frequency of Buying
6. Historical Overview (Market Origins, Product Launch
Timeline, etc.)
7. Pricing Analysis
8. Market Dynamics
8.1. Macroeconomic Factors
8.2. Drivers
8.2.1. Supply Side
8.2.2. Demand Side
8.3. Restraints
8.4. Opportunities
9. R&D Status and Technology Overview
10. Global 3D Cell Culture Market Analysis, By Technique
10.1.Introduction
10.2.Prominent Trends
10.3.Regulatory Guidelines
10.4.Market Size and Analysis, By Technique
10.4.1. Scaffold Based
10.4.1.1. Polymeric Hard Scaffolds
10.4.1.2. Biologic Scaffolds (Hydrogels)
10.4.1.3. Micropatterned Surface Microplates
10.4.2. Non-Scaffold Based
10.4.2.1. Hanging Drop Microplates
10.4.2.2. Spheroid Microplates containing Ultra-
Low Attachment (ULA) coating
10.4.2.3. Microfluidic 3D Cell Culture
10.4.3. Bioreactors
10.4.4. Magnetic Levitation and 3D Bioprinting
10.5.Market Share Analysis and YoY Growth Rates, By
Technique
11. Global 3D Cell Culture Market Analysis, By Product Type
11.1. Introduction
11.2.Prominent Trends
11.3.Regulatory Guidelines
11.4. Market Size and Analysis, By Product Type
11.4.1. 3D Cell Culture Platforms and Instruments
11.4.2. Culture Media and Materials
11.4.3. 3D Cell Culture and Assay Kits
11.4.4. End-use Specific Models
11.4.5. Others
11.5. Market Share Analysis and YoY Growth Rates, By
Product Type
12. Global 3D Cell Culture Market Analysis, By Applications
12.1. Introduction
12.2.Prominent Trends
12.3.Regulatory Guidelines
12.4. Market Size and Analysis, By Applications
12.4.1. Laboratory Research
12.4.1.1. Cancer & Stem Cell Research
12.4.1.2. Others
12.4.2. Clinical and Regenerative Medicine Applications
(Tissue Engineering)
12.4.3. Personalized Medicine
12.4.4. Drug Discovery (High-throughput Screening
(HTS)) and Testing
12.4.5. High Volume Cell Production
12.4.6. Others
12.5. Market Share Analysis and YoY Growth Rates, By
Applications
13. Global 3D Cell Culture Market Analysis, By End User
13.1. Introduction
13.2.Prominent Trends
13.3.Regulatory Guidelines
13.4. Market Size and Analysis, By End User
13.4.1. Biotechnology and Pharmaceutical Companies
13.4.2. Research Laboratories
13.4.3. Hospitals & Diagnostic Centers
13.4.4. Cosmetics & Chemical Industries
13.5. Market Share Analysis and YoY Growth Rates, By End
User
14. Global 3D Cell Culture Market Analysis, By Region
14.1.Introduction
14.2.Prominent Trends
14.3.Regulatory Guidelines
14.4.Market Size and Analysis, By Region
14.4.1. North America
14.4.2. Latin America
14.4.3. Europe
14.4.4. Asia Pacific
14.4.5. Middle East & Africa (MEA)
14.5.Market Share Analysis and YoY Growth Rates, By Region
15. North America 3D Cell Culture Market Analysis
15.1.Introduction
15.2.Prominent Trends
15.3.North America 3D Cell Culture Market Analysis, by
Country
15.3.1. U.S.
15.3.2. Canada
15.4.North America 3D Cell Culture Market Size and
Analysis, By Technique
15.4.1. Scaffold Based
15.4.1.1. Polymeric Hard Scaffolds
15.4.1.2. Biologic Scaffolds (Hydrogels)
15.4.1.3. Micropatterned Surface Microplates
15.4.2. Non-Scaffold Based
15.4.2.1. Hanging Drop Microplates
15.4.2.2. Spheroid Microplates containing Ultra-
Low Attachment (ULA) coating
15.4.2.3. Microfluidic 3D Cell Culture
15.4.3. Bioreactors
15.4.4. Magnetic Levitation and 3D Bioprinting
15.5.North America 3D Cell Culture Market Analysis, By
Product Type
15.5.1. Introduction
15.5.2. Prominent Trends
15.5.3. Regulatory Guidelines
15.5.4. Market Size and Analysis, By Product Type
15.5.4.1. 3D Cell Culture Platforms and
Instruments
15.5.4.2. Culture Media and Materials
15.5.4.3. 3D Cell Culture and Assay Kits
15.5.4.4. End-use Specific Models
15.5.4.5. Others
15.6.North America 3D Cell Culture Market Size and
Analysis, By Applications
15.6.1. Laboratory Research
15.6.1.1. Cancer & Stem Cell Research
15.6.1.2. Others
15.6.2. Clinical and Regenerative Medicine
Applications (Tissue Engineering)
15.6.3. Personalized Medicine
15.6.4. Drug Discovery (High-throughput Screening
(HTS)) and Testing
15.6.5. High Volume Cell Production
15.6.6. Others
15.7. North America 3D Cell Culture Market Size and
Analysis, By End User
15.7.1. Biotechnology and Pharmaceutical Companies
15.7.2. Research Laboratories
15.7.3. Hospitals & Diagnostic Centers
15.7.4. Cosmetics & Chemical Industries
15.8.Market Share Analysis and YoY Growth Rates
15.8.1. By Country
15.8.2. By Technique
15.8.3. By End User
15.8.4. By Applications
15.8.5. By Product Type
16. Latin America 3D Cell Culture Market Analysis
16.1.Introduction
16.2.Prominent Trends
16.3.Latin America 3D Cell Culture Market Analysis, by
Country
16.3.1. Mexico
16.3.2. Brazil
16.3.3. Others
16.4.Latin America 3D Cell Culture Market Size and Analysis,
By Technique
16.4.1. Scaffold Based
16.4.1.1. Polymeric Hard Scaffolds
16.4.1.2. Biologic Scaffolds (Hydrogels)
16.4.1.3. Micropatterned Surface Microplates
16.4.2. Non-Scaffold Based
16.4.2.1. Hanging Drop Microplates
16.4.2.2. Spheroid Microplates containing Ultra-
Low Attachment (ULA) coating
16.4.2.3. Microfluidic 3D Cell Culture
16.4.3. Bioreactors
16.4.4. Magnetic Levitation and 3D Bioprinting
16.5.Latin America 3D Cell Culture Market Analysis, By
Product Type
16.5.1. Introduction
16.5.2. Prominent Trends
16.5.3. Regulatory Guidelines
16.5.4. Market Size and Analysis, By Product Type
16.5.4.1. 3D Cell Culture Platforms and
Instruments
16.5.4.2. Culture Media and Materials
16.5.4.3. 3D Cell Culture and Assay Kits
16.5.4.4. End-use Specific Models
16.5.4.5. Others
16.6.Latin America 3D Cell Culture Market Size and Analysis,
By Applications
16.6.1. Laboratory Research
16.6.1.1. Cancer & Stem Cell Research
16.6.1.2. Others
16.6.2. Clinical and Regenerative Medicine
Applications (Tissue Engineering)
16.6.3. Personalized Medicine
16.6.4. Drug Discovery (High-throughput Screening
(HTS)) and Testing
16.6.5. High Volume Cell Production
16.6.6. Others
16.7. Latin America 3D Cell Culture Market Size and Analysis,
By End User
16.7.1. Biotechnology and Pharmaceutical Companies
16.7.2. Research Laboratories
16.7.3. Hospitals & Diagnostic Centers
16.7.4. Cosmetics & Chemical Industries
16.8.Market Share Analysis and YoY Growth Rates
16.8.1. By Country
16.8.2. By Technique
16.8.3. By End User
16.8.4. By Applications
16.8.5. By Product Type
17. Europe 3D Cell Culture Market Analysis
17.1.Introduction
17.2.Prominent Trends
17.3.Europe 3D Cell Culture Market Analysis, by Country
17.3.1. Germany
17.3.2. U.K.
17.3.3. Spain
17.3.4. France
17.3.5. Italy
17.3.6. Russia
17.3.7. Others
17.4.Europe 3D Cell Culture Market Size and Analysis, By
Technique
17.4.1. Scaffold Based
17.4.1.1. Polymeric Hard Scaffolds
17.4.1.2. Biologic Scaffolds (Hydrogels)
17.4.1.3. Micropatterned Surface Microplates
17.4.2. Non-Scaffold Based
17.4.2.1. Hanging Drop Microplates
17.4.2.2. Spheroid Microplates containing Ultra-
Low Attachment (ULA) coating
17.4.2.3. Microfluidic 3D Cell Culture
17.4.3. Bioreactors
17.4.4. Magnetic Levitation and 3D Bioprinting
17.5.Europe 3D Cell Culture Market Analysis, By Product
Type
17.5.1. Introduction
17.5.2. Prominent Trends
17.5.3. Regulatory Guidelines
17.5.4. Market Size and Analysis, By Product Type
17.5.4.1. 3D Cell Culture Platforms and
Instruments
17.5.4.2. Culture Media and Materials
17.5.4.3. 3D Cell Culture and Assay Kits
17.5.4.4. End-use Specific Models
17.5.4.5. Others
17.6.Europe 3D Cell Culture Market Size and Analysis, By
Applications
17.6.1. Laboratory Research
17.6.1.1. Cancer & Stem Cell Research
17.6.1.2. Others
17.6.2. Clinical and Regenerative Medicine
Applications (Tissue Engineering)
17.6.3. Personalized Medicine
17.6.4. Drug Discovery (High-throughput Screening
(HTS)) and Testing
17.6.5. High Volume Cell Production
17.6.6. Others
17.7. Europe 3D Cell Culture Market Size and Analysis, By
End User
17.7.1. Biotechnology and Pharmaceutical Companies
17.7.2. Research Laboratories
17.7.3. Hospitals & Diagnostic Centers
17.7.4. Cosmetics & Chemical Industries
17.8.Market Share Analysis and YoY Growth Rates
17.8.1. By Country
17.8.2. By Technique
17.8.3. By End User
17.8.4. By Applications
17.8.5. By Product Type
18. Asia Pacific 3D Cell Culture Market Analysis
18.1.Introduction
18.2.Prominent Trends
18.3.Asia Pacific 3D Cell Culture Market Analysis, by Country
18.3.1. India
18.3.2. China
18.3.3. Australia & New Zealand
18.3.4. Japan
18.3.5. Others
18.4.Asia Pacific 3D Cell Culture Market Size and Analysis, By
Technique
18.4.1. Scaffold Based
18.4.1.1. Polymeric Hard Scaffolds
18.4.1.2. Biologic Scaffolds (Hydrogels)
18.4.1.3. Micropatterned Surface Microplates
18.4.2. Non-Scaffold Based
18.4.2.1. Hanging Drop Microplates
18.4.2.2. Spheroid Microplates containing Ultra-
Low Attachment (ULA) coating
18.4.2.3. Microfluidic 3D Cell Culture
18.4.3. Bioreactors
18.4.4. Magnetic Levitation and 3D Bioprinting
18.5.Asia Pacific 3D Cell Culture Market Analysis, By Product
Type
18.5.1. Introduction
18.5.2. Prominent Trends
18.5.3. Regulatory Guidelines
18.5.4. Market Size and Analysis, By Product Type
18.5.4.1. 3D Cell Culture Platforms and
Instruments
18.5.4.2. Culture Media and Materials
18.5.4.3. 3D Cell Culture and Assay Kits
18.5.4.4. End-use Specific Models
18.5.4.5. Others
18.6.Asia Pacific 3D Cell Culture Market Size and Analysis, By
Applications
18.6.1. Laboratory Research
18.6.1.1. Cancer & Stem Cell Research
18.6.1.2. Others
18.6.2. Clinical and Regenerative Medicine
Applications (Tissue Engineering)
18.6.3. Personalized Medicine
18.6.4. Drug Discovery (High-throughput Screening
(HTS)) and Testing
18.6.5. High Volume Cell Production
18.6.6. Others
18.7. Asia Pacific 3D Cell Culture Market Size and Analysis,
By End User
18.7.1. Biotechnology and Pharmaceutical Companies
18.7.2. Research Laboratories
18.7.3. Hospitals & Diagnostic Centers
18.7.4. Cosmetics & Chemical Industries
18.8.Market Share Analysis and YoY Growth Rates
18.8.1. By Country
18.8.2. By Technique
18.8.3. By End User
18.8.4. By Applications
18.8.5. By Product Type
19. Middle East and Africa (MEA) 3D Cell Culture Market
Analysis
19.1.Introduction
19.2.Prominent Trends
19.3.Middle East and Africa 3D Cell Culture Market Analysis,
by Country
19.3.1. GCC countries
19.3.2. South Africa
19.3.3. North Africa
19.3.4. Rest of Middle East and Africa
19.4.Middle East and Africa 3D Cell Culture Market Size and
Analysis, By Technique
19.4.1. Scaffold Based
19.4.1.1. Polymeric Hard Scaffolds
19.4.1.2. Biologic Scaffolds (Hydrogels)
19.4.1.3. Micropatterned Surface Microplates
19.4.2. Non-Scaffold Based
19.4.2.1. Hanging Drop Microplates
19.4.2.2. Spheroid Microplates containing Ultra-
Low Attachment (ULA) coating
19.4.2.3. Microfluidic 3D Cell Culture
19.4.3. Bioreactors
19.4.4. Magnetic Levitation and 3D Bioprinting
19.5.Middle East and Africa 3D Cell Culture Market Analysis,
By Product Type
19.5.1. Introduction
19.5.2. Prominent Trends
19.5.3. Regulatory Guidelines
19.5.4. Market Size and Analysis, By Product Type
19.5.4.1. 3D Cell Culture Platforms and
Instruments
19.5.4.2. Culture Media and Materials
19.5.4.3. 3D Cell Culture and Assay Kits
19.5.4.4. End-use Specific Models
19.5.4.5. Others
19.6.Middle East and Africa 3D Cell Culture Market Size and
Analysis, By Applications
19.6.1. Laboratory Research
19.6.1.1. Cancer & Stem Cell Research
19.6.1.2. Others
19.6.2. Clinical and Regenerative Medicine
Applications (Tissue Engineering)
19.6.3. Personalized Medicine
19.6.4. Drug Discovery (High-throughput Screening
(HTS)) and Testing
19.6.5. High Volume Cell Production
19.6.6. Others
19.7. Middle East and Africa 3D Cell Culture Market Size and
Analysis, By End User
19.7.1. Biotechnology and Pharmaceutical Companies
19.7.2. Research Laboratories
19.7.3. Hospitals & Diagnostic Centers
19.7.4. Cosmetics & Chemical Industries
19.8.Market Share Analysis and YoY Growth Rates
19.8.1. By Country
19.8.2. By Technique
19.8.3. By End User
19.8.4. By Applications
19.8.5. By Product Type
20. Industry Structure
20.1. Porters Five Forces Analysis
20.1.1. Bargaining Power of Suppliers
20.1.2. Bargaining Power of Buyers
20.1.3. Threat of New Entrants
20.1.4. Threat of Substitute Products and Services
20.1.5. Internal Rivalry
20.2.Supply Chain Analysis and Profitability Margins
20.3.Market Share Analysis
20.4. Strategic Analysis
20.4.1. Competitive Strategies
20.4.2. Mergers & Acquisitions Activity
20.4.3. Co-operative Agreements
20.5. Critical Success Factor (CSF) Analysis (Technology &
Manufacturing, Design & Features, Brand Reputation, Distribution
Network, Marketing)
20.6.Company Profiles (Overview, Product/Service Details,
Geographic Scope, Financials, Strategic Intent & Approach, Core
Competencies & Competitive Advantage and Key developments)
20.6.1. InSphero
20.6.2. Merck KGaA
20.6.3. Thermo Fisher Scientific
20.6.4. Lonza Group
20.6.5. Promega Corporation
20.6.6. Synthecon, Incorporated
20.6.7. Nano3D Biosciences
20.6.8. 3D Biotek LLC
20.6.9. Pelo Biotech
20.6.10. 3D Biomatrix
20.6.11. Lena Biosciences, Inc.
20.6.12. Corning Incorporated
20.6.13. The Electrospinning Company
20.6.14. ReproCELL Europe Ltd
20.6.15. CN Bio Innovations
20.6.16. Stemtek Therapeutics
20.6.17. Kuraray Europe GmbH
20.6.18. QGel SA
20.6.19. MIMETAS
21. Prognosis for the Future
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
